The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...
The WHO issued guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment.
When COVID-19 swept the globe in 2020, the shock exposed not only a viral threat but the fragility of systems — from supply chains and food security to governance and global finance. For Andrea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback